Nextremity Solutions, Inc. Receives FDA 510(k) Clearance for Cannulated Hammertoe System
Retrieved on:
Friday, July 3, 2020
The DuoHex CH System addresses hammertoe deformity in patients and provides surgeons with a novel two-piece threaded implant construct is designed for optimum bone purchase.
Key Points:
- The DuoHex CH System addresses hammertoe deformity in patients and provides surgeons with a novel two-piece threaded implant construct is designed for optimum bone purchase.
- The design of the cannulated implants and instruments provide targeting and technique guidance for repeatable outcomes.
- Ryan Schlotterback, Chief Technology Officer for Nextremity Solutions said, "Nextremity Solutions was founded years ago by surgeons with a passion for the foot and ankle market and with an innovative solution for hammertoe correction.
- The Nextremity Solutions DuoHex CH Cannulated Hammertoe System is indicated for small bone reconstruction limited to interphalangeal repair and fusion of the lesser toes.